Literature DB >> 24430363

Impact of chemokines CCR5∆32, CXCL12G801A, and CXCR2C1208T on bladder cancer susceptibility in north Indian population.

Vibha Singh1, Praveen Kumar Jaiswal, Rohit Kapoor, Rakesh Kapoor, Rama Devi Mittal.   

Abstract

Chemokines are small inducible pro-inflammatory cytokines. In the present study, we tested association of chemokine single nucleotide polymorphisms (SNPs) viz., CCR5∆32, CXCL12G801A and CXCR2C1208T genes in bladder cancer (BC) patients and normal healthy controls of north Indians. Genotyping of the above SNPs were done in 200 BC cases and 200 healthy controls, using RFLP and amplification refractory mutation system-polymerase chain reaction methodology. A significant association was found in CXCL12G801A with BC risk. In case of CXCL12G801A polymorphism, the heterozygous (GA) genotype showed significantly high risk (p < 0.001, odds ratio (OR) = 2.72), whereas A allele carrier (GA + AA) also showed risk with BC (p < 0.001, OR = 2.44). In CXCR2C1208T polymorphism, the variant genotype (TT) showed significant risk for BC (p = 0.028, OR = 1.58). The variant allele (T) of CXCR2C1208T polymorphism was found to be associated with BC risk (p = 0.003, OR = 1.29). Interestingly, smoking was also found to modulate 1.16-fold risks for BC in case of CXCR2C1208T, variant genotype (TT). Upon analyzing the gene-gene interaction between CXCR2C1208T and CXCL12G801A, the combination CT-GA showed 4-fold risk for BC (p = 0.009). Our results indicated that polymorphism in CXCR2C1208T and CXCL12G801A showed high risk for BC in north Indian population. However, CCR5∆32 exhibited no association. Study with large sample size and diverse ethnicity are required to validate these observations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430363     DOI: 10.1007/s13277-014-1624-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis.

Authors:  Patricia Hartstein Salim; Mariana Jobim; Markus Bredemeier; José Arthur Bogo Chies; João Carlos Tavares Brenol; Luiz Fernando Jobim; Ricardo Machado Xavier
Journal:  Cytokine       Date:  2012-07-03       Impact factor: 3.861

2.  Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.

Authors:  Joseph Kim; Takuji Mori; Steven L Chen; Farin F Amersi; Steve R Martinez; Christine Kuo; Roderick R Turner; Xing Ye; Anton J Bilchik; Donald L Morton; Dave S B Hoon
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

Authors:  Ferruh K Işman; Canan Kucukgergin; Selçuk Daşdemir; Bedia Cakmakoglu; Oner Sanli; Sule Seckin
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

Review 4.  Platelet-derived CXC chemokines: old players in new games.

Authors:  E Brandt; A Ludwig; F Petersen; H D Flad
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

5.  CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer.

Authors:  Lukasz Kruszyna; Margarita Lianeri; Błażej Rubis; Hanna Knuła; Maria Rybczyńska; Sylwia Grodecka-Gazdecka; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2010-06-20       Impact factor: 2.316

6.  Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children.

Authors:  J Javor; M Bucova; O Cervenova; K Kralinsky; E Sadova; M Suchankova; A Liptakova
Journal:  Int J Immunogenet       Date:  2012-02-10       Impact factor: 1.466

7.  A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer.

Authors:  Eleftherios Vairaktaris; Antonis Vylliotis; Sofia Spyridonodou; Spyridoula Derka; Stavros Vassiliou; Emeka Nkenke; Christos Yapijakis; Zoe Serefoglou; Friedrich W Neukam; Efstratios Patsouris
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

8.  Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.

Authors:  Stavros Apostolakis; Stavroula Baritaki; Georgios E Kochiadakis; Nikolaos E Igoumenidis; Dimitrios Panutsopulos; Demetrios A Spandidos
Journal:  Thromb Res       Date:  2006-02-09       Impact factor: 3.944

9.  Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.

Authors:  M Rüster; H Sperschneider; R Fünfstück; G Stein; H J Gröne
Journal:  Clin Nephrol       Date:  2004-01       Impact factor: 0.975

10.  Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.

Authors:  Tarunveer Singh Ahluwalia; Madhu Khullar; Monica Ahuja; Harbir Singh Kohli; Anil Bhansali; Viswanathan Mohan; Radha Venkatesan; Taranjit Singh Rai; Kamal Sud; Pawan K Singal
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more
  5 in total

1.  The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.

Authors:  Ke Zhu; Benchun Jiang; Rong Hu; Ying Yang; Miao Miao; Yingchun Li; Zhuogang Liu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

2.  Association between IL8RB C1208T mutation and risk of cancer: A pooled analysis based on 5299 cases and 6899 controls.

Authors:  He-Yun Sun; Zhi-Chao Min; Lei Gao; Zi-Yi Zhang; Ting-Le Pang; Ying-Jun Gao; Hong Pan; Jun Ou-Yang
Journal:  Medicine (Baltimore)       Date:  2022-02-25       Impact factor: 1.817

3.  The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants.

Authors:  Xiang Tong; Yao Ma; Huajiang Deng; Xixi Wang; Sitong Liu; Zhipeng Yan; Shifeng Peng; Hong Fan
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

4.  Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility.

Authors:  Jing Zhou; Hao Wu; Quan-Xin Su; Xiao-Kai Shi; Bo-Wen Tang; Cui-Ping Zhao; Hai Wang; Xiao-Ping Chen
Journal:  J Immunol Res       Date:  2021-10-14       Impact factor: 4.818

5.  Effect of interleukin-8 receptor B (IL8RB) rs1126579 C>T variation on the risk to cancer.

Authors:  Lihong Zhu; Bowen Tang; Ze Zhang; Shuzhang Wei; Zhiwei Lv; Yujuan Zhang; Minlie Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.